The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
1111472710 11114727 10 F 20150110 20160822 20150515 20160829 EXP PHHY2012CA123222 SANDOZ 55.62 YR M Y 0.00000 20160829 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
1111472710 11114727 1 SS XOLAIR OMALIZUMAB 1 Subcutaneous 300 MG, EVERY 4 WEEKS U 0 300 MG VIAL
1111472710 11114727 2 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1111472710 11114727 3 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1111472710 11114727 4 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0062/ S0060A 0 VIAL
1111472710 11114727 5 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U S0003B 0 VIAL
1111472710 11114727 6 SS XOLAIR OMALIZUMAB 1 Subcutaneous UNK U 0 VIAL
1111472710 11114727 7 SS DIOVAN VALSARTAN 1 Unknown U 0
1111472710 11114727 8 PS PREDNISONE. PREDNISONE 1 Unknown 80336
1111472710 11114727 9 SS PREDNISONE. PREDNISONE 1 Oral UNK 80336
1111472710 11114727 10 SS PREDNISONE. PREDNISONE 1 Oral 50 MG, QD (5 DAY COURSE) 80336 50 MG QD
1111472710 11114727 11 SS PREDNISONE. PREDNISONE 1 Unknown 50 MG (5 DAY COURSE) 80336 50 MG
1111472710 11114727 12 SS PREDNISONE. PREDNISONE 1 Oral 50 MG (10 DAY COURSE) 80336 50 MG
1111472710 11114727 13 SS SPIRIVA TIOTROPIUM BROMIDE MONOHYDRATE 1 Unknown 18 UG, QD U 0 18 UG QD
1111472710 11114727 14 C PANTOLOC//PANTOPRAZOLE SODIUM SESQUIHYDRATE PANTOPRAZOLE SODIUM 1 Unknown U 0
1111472710 11114727 15 C CALCIUM CALCIUM 1 Unknown U 0
1111472710 11114727 16 C VITAMIN D CHOLECALCIFEROL 1 Unknown U 0
1111472710 11114727 17 C ALENDRONATE ALENDRONATE SODIUM 1 Unknown U 0
1111472710 11114727 18 C ADVAIR HFA FLUTICASONE PROPIONATESALMETEROL XINAFOATE 1 Unknown U 0
1111472710 11114727 19 C IPRATROPIUM IPRATROPIUM 1 Unknown U 0
1111472710 11114727 20 C SINGULAIR MONTELUKAST SODIUM 1 Unknown U 0
1111472710 11114727 21 C SYMBICORT BUDESONIDEFORMOTEROL FUMARATE DIHYDRATE 1 Unknown U 0
1111472710 11114727 22 C VENTOLIN ALBUTEROL SULFATE 1 Unknown U 0
1111472710 11114727 23 C METHOTREXATE. METHOTREXATE 1 Unknown U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
1111472710 11114727 1 Asthma
1111472710 11114727 7 Product used for unknown indication
1111472710 11114727 8 Product used for unknown indication
1111472710 11114727 13 Product used for unknown indication
1111472710 11114727 14 Product used for unknown indication
1111472710 11114727 15 Product used for unknown indication
1111472710 11114727 16 Product used for unknown indication
1111472710 11114727 17 Product used for unknown indication
1111472710 11114727 18 Product used for unknown indication
1111472710 11114727 19 Product used for unknown indication
1111472710 11114727 20 Product used for unknown indication
1111472710 11114727 21 Product used for unknown indication
1111472710 11114727 22 Product used for unknown indication
1111472710 11114727 23 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
1111472710 11114727 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
1111472710 11114727 Asthma
1111472710 11114727 Asthma-chronic obstructive pulmonary disease overlap syndrome
1111472710 11114727 Blood pressure increased
1111472710 11114727 Chest discomfort
1111472710 11114727 Cough
1111472710 11114727 Cushing's syndrome
1111472710 11114727 Dyspnoea
1111472710 11114727 Dyspnoea exertional
1111472710 11114727 Forced expiratory volume decreased
1111472710 11114727 Heart rate increased
1111472710 11114727 Hypoventilation
1111472710 11114727 Obstructive airways disorder
1111472710 11114727 Productive cough
1111472710 11114727 Respiratory tract congestion
1111472710 11114727 Restrictive pulmonary disease
1111472710 11114727 Sensitivity to weather change
1111472710 11114727 Sputum discoloured
1111472710 11114727 Upper respiratory tract infection
1111472710 11114727 Weight decreased
1111472710 11114727 Wheezing

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
1111472710 11114727 1 20120425 0
1111472710 11114727 2 20150112 0
1111472710 11114727 3 20160113 0
1111472710 11114727 4 20160309 0
1111472710 11114727 5 20160727 0
1111472710 11114727 6 20160822 0
1111472710 11114727 8 201508 0
1111472710 11114727 9 201509 0
1111472710 11114727 10 201511 0
1111472710 11114727 11 201602 0